Evotec SE (ETR:EVT)
5.40
-0.06 (-1.13%)
At close: Mar 6, 2026
Evotec SE Market Cap
Evotec SE has a market cap or net worth of €957.9 million as of March 6, 2026. Its market cap has decreased by -37.14% in one year.
Market Cap
957.90M
Enterprise Value
1.21B
Revenue
756.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.40
Market Cap Chart
Since November 11, 1999, Evotec SE's market cap has increased from 4.47M to 957.90M, an increase of 21,321.12%. That is a compound annual growth rate of 22.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 957.90M | -0.88% |
| Dec 30, 2025 | 966.41M | -33.49% |
| Dec 30, 2024 | 1.45B | -61.41% |
| Dec 29, 2023 | 3.77B | 39.63% |
| Dec 30, 2022 | 2.70B | -63.78% |
| Dec 30, 2021 | 7.44B | 50.39% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 49.22B |
| Siemens Healthineers AG | 45.19B |
| Bayer Aktiengesellschaft | 37.11B |
| Fresenius SE & Co. KGaA | 26.13B |
| Carl Zeiss Meditec AG | 2.22B |
| SCHOTT Pharma AG & Co. KGaA | 2.14B |
| Dermapharm Holding SE | 2.06B |
| Eckert & Ziegler SE | 951.75M |